Home / Europe / Germany / Tax

Tax

Providing comprehensive advice on national and international tax issues is one of CMS's core competencies. Our excellently networked tax team combines broad expertise with specialisations and many years of experience in advising companies, groups, family businesses and family offices, financial institutions, private individuals, non-profit organisations (NPOs) and the public sector at numerous locations throughout Germany and internationally. 

Our team supports you in all tax areas, including transfer pricing issues and specialised tax matters. In addition, we support our clients in tax disputes not only in the run-up to a legal dispute, but also represent them before the fiscal courts. 

Focal points

Our areas of specialisation include in particular

  • Corporate and group tax law
  • Tax support for M&A and PMI projects
  • Advice on external audits and tax disputes (in and out of court)
  • Tax compliance (prevention, defence advice and defence)
  • Real estate tax law
  • Investment tax law (fund structuring and fund investments)
  • Taxation of the digital economy (crypto and blockchain)
  • Indirect taxes (VAT, insurance tax, energy and excise duties) and customs duties
  • Tax advice in insolvency and crisis situations
  • Succession taxation and HNWIs

Future-facing - forward-looking and sustainable tax advice

The complexity of the national and global tax landscape is constantly and rapidly increasing. This presents companies, entrepreneurs and private individuals with ever new challenges. We keep an eye on all tax law developments for you and support you in reacting to them in good time with forward-looking and sustainable solutions. 

Our expertise is not limited to the legal aspects. We understand the economic environment in which our clients operate and translate our customised advice into efficient and pragmatic solutions. 

Interdisciplinary and international - customised solutions from a single source 

Almost every legal and life situation is associated with tax law issues. Our experienced teams have a trained eye for the interrelationships and work closely with all other practice areas and legal fields at CMS. 

Depending on the individual requirements of your project, we regularly work with other CMS legal disciplines, such as labour law, corporate M&A, private clients, real estate & public or restructuring and insolvency, or call in the relevant CMS experts for you. 

We also advise and coordinate international issues and cross-border mandates for you in international teams, depending on the requirements of the individual case. 

With over 500 CMS tax experts in more than 40 jurisdictions, we ensure that your interests are represented worldwide and realised from a single source.

Choose area

Erbschaftsteuerliche Optimierung
Inheritance Tax Planning
Tax efficient ways to bequeath an estate or give a lifetime gift. The German population has collectively generated huge amounts of private wealth that
Post Merger Integration
Post-merger integration (PMI)
The closing marks the end of a successful acquisition process, but not the end of the challenge of the deal itself. Expectations of a corporate transa
Umstrukturierung von Firmenstrukturen
Reorganising Company Structures
We can optimise your corporate architecture. Company structures often evolve over a long period of time and are further complicated by acquisitions. I
Steuerliche Sonderfragen
Specialist Tax Matters
Unusual requirements are our speciality. The comprehensive advisory work of CMS GmbH Steuerberatungsgesellschaft includes specialist tax matters acros
Strukturierung von Immobilieninvestments
Structuring of Real Estate Investments
We maximise the tax efficiency of your real estate investment. Property transfer tax is an important topic when investing in real estate, as is VAT in
Unternehmensnachfolge
Tax Aspects of Corporate Succession
Enabling a stress-free handover. For many medium-sized companies, it will soon be time to hand over the business to the next generation. There are var
Tax Compliance
Our experts work with you to implement regulatory requirements without creating unnecessary bureaucratic obstacles.Overview of our expertise:. Non-fin
Steuern bei M&A Transaktionen
Taxes in M&A transactions
You are planning to buy or sell a company, would like to merge or set up a joint venture? The challenges and measures which need to be considered in o

How can we advise you?

Send us a message and we will get back to you.

Your message was sent.

Thank you for contacting us. We will get back to you soon.

Please check these fields.

By including your personal data on this form you agree to it being used in accordance with our Privacy Policy

sending...
14/03/2022
Post-Merger Integration - CMS PMI services
CMS PMI services
14/07/2020
Disclosure Requirements for Cross-border Tax Arrangements
New disclosure requirements under DAC 6 On 25 June 2018, the sixth amendment to the EU Directive on Administrative Cooperation (2011 / 16 / EU) on man­dat­ory auto­mat­ic exchange of information in the...

Feed

26/03/2024
CMS advises SEFE on all aspects of acquiring WIGA Group
Hamburg – SEFE Securing Energy for Europe GmbH (SEFE) has acquired all the shares in WIGA Transport Beteili­gungs-GmbH & Co. KG (WIGA) from its co-shareholder Wintershall Dea AG. The transaction is currently awaiting approval from the competition authorities. SEFE is wholly owned by the Federal Republic of Germany. WIGA owns regulated gas pipeline operators GASCADE Gastransport GmbH and NEL Gastransport GmbH, who operate one of the largest high-pressure gas networks in Germany with a combined length of around 4,150 kilometres. These networks have a key role to play in European energy security and the green energy transformation. The transaction will strengthen SEFE in its role of ensuring secure and reliable energy supply in Germany and Europe, as well as boosting its hydrogen ex­pert­ise.“With the full acquisition of WIGA as sole shareholder, we are strategically strengthening SEFE as an independent and autonomous midstream company,” commented Reinhard Gorenflos, Chairman of the SEFE Supervisory Board.“SEFE being the sole shareholder of WIGA will ensure that GASCADE can convert the existing high-performance infrastructure to hydrogen in the future. In this way, we can help drive forward the green energy transformation. Transportation infrastructure is a pivotal part of the future hydrogen value chain,” said Dr Egbert Laege, CEO of SEFE. “The two WIGA subsidiaries, GASCADE and NEL, will continue to operate independently and market their capacity in a transparent and non-dis­crim­in­at­ory manner.”SEFE CFO Dr Christian Ohlms highlighted the importance of WIGA with regard to the privatisation of SEFE, which is due to take place by the end of 2028: “With this transaction, which is expected to complete by summer 2024, we are strengthening SEFE’s asset base. Our aim is to continue the long-term development of SEFE on a stable financial footing.”A multinational CMS team headed by Hamburg-based partner Dr Holger Kraft advised SEFE on all aspects of acquiring WIGA. In addition to extensive due diligence on the entire WIGA Group, including GASCADE and NEL, which are regulated under energy law, this work covered negotiation of the share purchase agreement and separate agreements with the shareholders of Wintershall Dea AG. Alongside negotiating the transaction agreements, the advice focused on safeguarding the transaction through several W&I insurance agreements, including negotiating the policies, and handling regulatory issues relating to gas network operation and other public-law matters. CMS Germany worked closely with the CMS law firms in the UK and Luxembourg, and with US law firm Faegre Drinker Biddle & Reath LLP. CMS previously advised the Federal Network Agency (BNetzA) and the Federal Ministry for Economic Affairs and Climate Action in 2022 and 2023 around their trusteeship over SEFE and its subsequent nationalisation by way of corporate actions. The instructions for this transaction followed on from that successful cooperation. About SEFE:As an integrated midstream energy company headquartered in Berlin, SEFE Securing Energy for Europe ensures the security of energy supply in Germany and Europe and is driving the green energy transformation. SEFE is active in trading & portfolio management, sales, transportation and storage of energy and has its strongest presence in Germany and the UK. SEFE employs around 1,500 people and supplies over 50,000 customers, in particular industrial customers and municipal utilities in Germany and seven other European markets. With a sales volume of around 200 TWh of power and gas, SEFE plays a central role in stability of the energy supply in Germany and Europe. SEFE is owned by the Federal Government of Germany. CMS Germany Dr Holger Kraft, Lead Partner Dr Jan Schepke, Partner Matthias Sethmann, Principal Counsel Dr Dirk Baukholt, Principal Coun­sel Char­lotte von der Heydt-von Kalckreuth, Counsel Dr Stefan Kühl, Senior Associate Dr Paul Kintrup, Senior Associate, all Corporate/M&A Dr Rolf Hempel, Partner Dr Friedrich von Burchard, Partner Nicole Köppen, Senior Associate, all Regulatory Dr Hermann Müller, Partner Dr Arno Görlitz, Associate, both Public Commercial Law Dr Martin Mohr, Partner Dr Olaf Thießen, Principal Counsel, both Tax Dr Alexandra Schluck-Amend, Partner Manuel Nann, Senior As­so­ci­ate Pit-Jo­hannes Wagner, Associate, all Restructuring Dr Andreas Hofelich, Partner Dr Mario Brungs, Counsel Dr Lena Pingen, Associate, all Em­ploy­ment/Pen­sions Dr Fritz von Hammerstein, Partner Jan Gröschel, Senior Associate Heike Weyer, Senior Associate, all Public Law Dr Stefan Voß, Partner Tamara Bux, Associate, both Real Estate Dr Sebastian Cording, Partner Martin Krause, Partner Dr Shaya Stender, Associate Joel Coché, Associate, all Commercial Dr Julia Runge, Principal Counsel, Finance Dr Michael Bauer, Part­ner Chris­toff Henrik Soltau, Partner Dr Robert Bodewig, Senior Associate Luisa Thomasberger, Associate, all Antitrust, Competition & Trade CMS UK Russel Hoare, Partner Sam De Silva, Part­ner Jean-Fran­cois Willems, Of Counsel Jennifer Louch, Senior As­so­ci­ate Max­imili­an Weaver, Senior Associate Louisa Mottaz, Associate CMS Luxembourg Angelique Eguether, Senior As­so­ci­ate Guil­laume Flagollet, Managing Associate Faegre Drinker Biddle & Reath LLP (USA) Mollie D. Sitkowski Inhouse at SEFE Securing Energy for Europe GmbH Dr Jörg Kammerer Jörn RimkePress Con­tact presse@cms-hs. com
26/03/2024
CMS advises sellers of Cardior Pharmaceuticals on potential acquisition...
Munich – CMS advises the sellers of Cardior Pharmaceuticals in the potential acquisition of the company by Novo Nordisk. Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved. The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart failure. The closing of the acquisition is subject to receipt of applicable regulatory approvals and other customary conditions. It is expected to happen in the second quarter of 2024.A CMS team headed by Lead Partners Stefan-Ulrich Müller, Dr Tilman Weichert and Jörg Schrade advised the sellers of Cardior Pharmaceuticals on all legal aspects of the transaction. Cardior Pharmaceuticals GmbH, based in Hannover, Germany, is a leading clinical-stage bio­phar­ma­ceut­ic­al company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. The company’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. CMS Germany Stefan-Ulrich Müller, Lead Partner Dr Tilman Weichert, Lead Partner Dr Michael Wangemann, Partner Dr Kai Wallisch, Partner Dr Thomas Mühl, Principal Coun­sel Se­basti­an Hummel, Senior As­so­ci­ate Vikt­or­ia Barthel, Senior As­so­ci­ate Mar­i­elouise Emmer, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Stefan Kühl, Senior Associate Dr Alexander Weinhold, Senior Associate Maria Kucher, Associate Jonas Ohmann, Associate Dr Josephine Doll, Associate Dr Christian Seeburger, Associate Sonja Schanze, Associate, all Corporate/M&A Dr Marie-Luisa Loheide, Associate, Private Clients Jörg Schrade, Lead Partner Eduard Kosavtsev, Senior Associate, both Tax Stefan Lehr, Partner, Antitrust, Competition & Trade Stefan Lüft, Partner, IP Dr Benedikt Forschner, Partner, Labor, Employment & Pensions Dr Markus Kaulartz, Partner Dr Fiona Savary, Counsel Dr Felix Glocker, Senior Associate, all TMC Dr Tilman Niedermaier, Partner Susanne Schwalb, Partner, both Dispute ResolutionPress Con­tact presse@cms-hs. com
25/03/2024
CMS advises on project financing for land-based terminal in Stade
Hamburg – Hanseatic Energy Hub GmbH (HEH) has achieved financial close for the project financing to develop and realise the planned terminal for liquefied gases in Stade. Total investment is some EUR 1.6 billion. Achieving financial close represents a major milestone for Hanseatic Energy Hub GmbH’s land-based terminal.A multi-dis­cip­lin­ary and multi-location CMS team headed by Dr Hilke Herchen and Dr Holger Kraft advised Hanseatic Energy Hub GmbH on developing the project and on preparations to secure the project financing. This included corporate law advice with a particular focus on developing and optimising corporate governance, and on the associated links to the project financing. This advice marks a continuation of the existing close cooperation between HEH and CMS. The CMS team has been providing advice on an ongoing basis since the start of the project, with support for project development around corporate, operation & maintenance and real estate matters in particular. This has included advising on various shareholders joining the project, with a recent example being Enagás S.A. as industrial partner in June 2023. The CMS team conducted a comprehensive due diligence check to put the project financing on a solid footing. The first expansion phase of the project will see an emission-free terminal begin operating in 2027. Its infrastructure is also approved for bio-LNG and synthetic natural gas (SNG). At a later stage, the project will be switched over to hydrogen-based energy carriers such as ammonia. The planned regasification capacity is 13.3 billion cubic metres per year and the send-out capacity is 21.7 gigawatt. From March 2024 until the onshore terminal becomes operational, Hanseatic Energy Hub GmbH will also accommodate one of the five FSRUs (Floating Storage and Regasification Units) chartered by the German federal government. CMS Germany Dr Hilke Herchen, Lead Partner Dr Holger Kraft, Lead Partner Matthias Sethmann, Principal Counsel Dr Luise Pelzer, Counsel Dr Stefan Kühl, Senior Associate Dr Carl-Friedrich Thoma, Senior Associate Dr Josephine Doll, As­so­ci­ate Domin­ic Zimmer, Associate Dr Christian Seeburger, Associate, all Corporate/M&A Dr Fritz von Hammerstein, Partner Katja Meisel, Senior Associate Jan Gröschel, Senior Associate, all Per­mit­ting Mar­tin Krause, Partner Dr Sebastian Orthmann, Partner Dr Hans Fabian Kiderlen, Principal Coun­sel Chris­toph­er Schmeckel, Senior Associate Wiebke Westermann, Associate, all Real Estate Dr Friedrich von Burchard, Partner, Energy & Climate Change Dorothée Janzen, Part­ner  Chris­toph Zarth, Partner Robin Azinovic, Associate, all Commercial Dr Kerstin Block, Partner, Banking & Finance  Dr Martin Mohr, Partner Dr Olaf Thießen, Principal Counsel, both Tax Dr Sebastian Cording, Partner Dr Anna Lena Füllsack, Senior Associate, both TMC Dr Michael Bauer, Partner Luisa Thomasberger, Associate, both Antitrust, Competition & Trade Dr Philipp Nonnenmühlen, Counsel, Labor, Employment & Pensions Dr Martin Gerecke, Partner, IP Birgit Wagner, Legal Manager, Smart OperationsPress Con­tact presse@cms-hs. com
12/03/2024
Multi-billion incentive programme for climate-friendly industry launched:...
Berlin – The German government is aiming to make German industry carbon-neutral by 2045. In line with this commitment, on Tuesday, 12 March 2024 the Federal Ministry for Economic Affairs and Climate Action launched the world’s first bidding process for a programme to fund climate action contracts. Based on carbon contracts for difference, these climate action contracts promote investment in climate-friendly production facilities that would not otherwise be economically viable at this point in time. The programme is primarily aimed at operators of emis­sion-in­tens­ive plants, such as in the steel, paper, chemicals, metal and glass industries. Climate action contracts provide an incentive to develop and build the required technologies and infrastructure in Germany now. This will not only avoid around 350 million tonnes of CO2 over the term of the funding programme up to 2045, but is also designed to kick-start the urgently needed market transformation while simultaneously setting new international standards for efficient, low-bureaucracy support. The climate action contracts are intended as both a key tool for climate change mitigation and to strengthen Germany as a country with a long history of industry and innovation. EUR 4 billion has been made available over a 15-year term for the initial bidding process that has now been opened. Companies that were successful in the preparatory phase in the summer of 2023 can apply to take part in the initial bidding process within the next four months. As Germany’s economics minister announced at today’s press conference, the second round of bidding will be conducted later in 2024, with EUR 19 billion available for this purpose. Two further rounds of bidding are scheduled for 2025.A CMS team headed by lead partner Dr Jürgen Frodermann advised the Federal Ministry for Economic Affairs and Climate Action on all aspects of subsidy, state aid, contract and energy law with regard to the support programme. The advice related in particular to drafting a funding policy and associated climate action contracts to be concluded between the state and companies eligible for funding. The work also included support around the notification procedure to the European Commission. In view of the pioneering nature of the funding programme, the CMS team had to deal with legal issues arising in connection with the programme in both a European and a national context, while also ensuring close alignment with the defined technical and economic objectives. The support was provided through an in­ter­dis­cip­lin­ary consortium headed by lead project manager Jülich, together with VDI/VDE Innovation + Technik and Deloitte. CMS Germany Dr Jürgen Frodermann, Lead Partner Dr Nico Hannemann, Senior Associate Dr Nora Zabel, Counsel Björn Hopen, Associate Nina Becker, Associate, all Contract Law Shaghayegh Smousavi, Partner, Energy / Regulation Dr Jakob Steiff, Partner Dr André Lippert, Partner Dr Sven Brockhoff, Counsel Dr Annchristin Streuber, As­so­ci­ate Con­stan­ze Schweidtmann, Associate, all Public Law / Subsidy Law Dr Michael Bauer, Partner Louisa Thomasberger, Associate, both State Aid Dr Martin Friedberg, Partner, TaxPress Con­tact presse@cms-hs. com
22/02/2024
Neue Chance für das Wach­stum­schan­cenge­setz
Welcome to the first 2024 podcast in the CMS To Go series "beigeSTEUERt", in which we look at the most important changes in tax legislation. Dr Martin Friedberg, Philine Lindner and Dr Hendrik Arendt present the most important new and upcoming rules around corporate tax law, including the Minimum Taxation Directive, the Financing for the Future Act (ZuFinG), the Secondary Credit Market Act (KrZwMG) and the Budget Financing Act (HFG). There is a special focus on the Growth Opportunities Act (WCG), which is aimed at making the German economy more in­vest­ment-friendly and competitive.
21/02/2024
CMS advises MVZ Laaff on sale to amedes
Stuttgart – The founder of medical laboratory MVZ Laaff, Prof. Helmut Laaff, has sold MVZ Laaff GmbH with its facilities in Freiburg, Heilbronn and Ulm to the amedes Group. amedes is a leading German lab services provider, operating a number of healthcare centres throughout Germany with different specialisations. MVZ Laaff provides services in fields of medicine including derma­to­path­o­logy, general pathology, immunohistology, molecular pathology and cytology, and is one of the leading laboratories in these specialist areas. Details of the transaction were not disclosed.A CMS team headed by lead partner Dr Christoph Lächler advised Prof. Helmut Laaff on all legal aspects of the transaction. The sale took place by way of an auction process. A particular focus of the advice was on structuring the transaction and the associated regulatory issues. CMS Germany Dr Christoph Lächler, Lead Part­ner Stefan-Ul­rich Müller, Partner Dr Jacob Siebert, Partner Viktoria Barthel, Senior Associate Tobias Kalski, Senior As­so­ci­ate An­dreas Kazmaier, Associate, all Corporate/M&A Dr Roland Wiring, Partner Dr Siham Hidar, Senior Associate, both Regulatory Dr Harald Kahlenberg, Partner Angelika Wieczorkowski, Senior Associate, both Antitrust, Competition & Trade Dr Stefan Voss, Partner Lukas Potstada, Counsel, both Real Estate Dr Martin Mohr, Partner, TaxPress Con­tact presse@cms-hs. com
21/02/2024
Das neue MoPeG: Welche Auswirkungen hat es auf das Steuerrecht?
On 1 January 2024, the Act to Modernise Partnership Law (MoPeG) entered into force. What is the tax law impact of the new, apparently innocuous amendments to civil law? In our latest "talkingTAX" podcast, Dr Martin Friedberg and Luise Uhl-Ludäscher deal with these questions and many other interesting issues in connection with the MoPeG. Have a listen.
21/02/2024
Die Reform der Zinsschranke
The German Parliament passed several new tax regulations at the turn of the year, including a reform of the interest barrier. The new rules, which were originally intended to be included in the Growth Opportunities Act, have now greatly extended the scope of the interest barrier. In our new podcast, Dr Hendrik Arendt and Dr Anastasia Papadelli explain the differences between the old and new rules. Have a listen.
20/02/2024
CMS advises HIRMER Group on sale of Travel Charme Hotels & Resorts to REWE...
Leipzig – The HIRMER Group has sold Travel Charme Hotel GmbH & Co. KG with its 13 exclusive hotels and resorts across Germany, Austria and Italy to DSR Hotel Holding GmbH. Travel Charme is regarded as an expert in the premium segment of the leisure hotel industry. It operates hotels in top locations, particularly in the Baltic region and in the Alps. The acquisition of Travel Charme boosts DSR Hotel Holding’s portfolio to a total of 35 hotels, thus expanding its market position in the German and Austrian holiday hotel sector. The transaction is currently awaiting approval from the merger control authorities. The parties agreed not to disclose further details.A CMS team headed by Dr Jochen Lux advised the HIRMER Group on all legal aspects of the sale. The company also relied on the expertise of CMS when it acquired Travel Charme in 2018. The Munich-based HIRMER Group is wholly owned by the Hirmer family. It employs some 1,800 people and operates in the fields of fashion retail, real estate management and development and in the hotel industry. DSR Hotel Holding is majority owned by DER Touristik, making it part of the REWE Group. It operates and markets a high-quality hotel portfolio comprising both growth-oriented hotel/resort brands and traditional individual hotels. CMS Germany Dr Jochen Lux, Lead Partner Dr Kevin Schmidt, Senior As­so­ci­ate Madeline Göbel, Senior As­so­ci­ate Theresa Bendix, Project Manager Nadine Fröhlich, Project Manager, all Corporate/M&A Dr Martin Mohr, Partner, Tax Dr Rolf Hempel, Partner Martin Cholewa, Counsel, both Antitrust, Competition & TradePress Con­tact presse@cms-hs. com
14/02/2024
CMS advises paint and coatings producer KANSAI HELIOS on the acquisition...
Cologne – KANSAI HELIOS has acquired the entire industrial coatings business of GREBE Holding, based in Weilburg in Hessen, Germany, which operates under the name WEILBURGER Coatings. WEILBURGER Coatings is a well-known manufacturer of industrial coatings and comprises of WEILBURGER Coatings GmbH in Weilburg and WEILBURGER Asia Limited in Hong Kong. The share purchase agreement was signed on February 9, 2024. With the acquisition, KANSAI HELIOS intends to significantly expand its strategic position as a system supplier and manufacturer of industrial coatings and extend its geographical presence internationally. The company will also gain additional expertise, distribution channels, production and storage capacities. The parties involved have agreed not to disclose further details of the transaction. An international CMS team headed by Lead Partner Klaus Jäger and Christoph Schröer provided KANSAI HELIOS with comprehensive legal advice on the acquisition. The complexity of the transaction is characterized in particular by the size of the acquired Weilburger Coatings Group, which, in addition to the German companies, includes subsidiaries in Brazil, China, France, Hong Kong, India, Italy, Turkey and the USA. In addition to the actual purchase agreements in Germany and Hong Kong, CMS drafted and negotiated numerous other contracts. In addition to CMS teams in Brazil, China, Hong Kong, Italy, Turkey, France, Serbia, Austria and the United Kingdom, the law firms MILLER & MARTIN PLLC from the USA and Vaish Associates Advocates from India also provided support. KANSAI HELIOS regularly relies on the expertise of CMS, most recently in connection with the acquisition of all shares in CWS Lackfabrik GmbH (CWS), which specializes in powder coatings and synthetic resins, including the group companies in Germany, the USA, Denmark and Poland. KANSAI HELIOS, headquartered in Vienna, is part of the Japanese KANSAI PAINT Group. The company has a history of more than 170 years and is one of the major global players in the paints and coatings market. KANSAI HELIOS designs, produces and distributes industrial coating solutions, bleaching and cleaning chemicals, materials for sticking and sealing, high-quality resins, architectural paints and refinishing coatings throughout Europe and beyond. WEILBURGER Coatings was founded in 1900 at its current headquarters in Weilburg and has group companies in Germany, Italy, France, Turkey, the USA, Brazil, India and China. With around 600 employees at seven production sites and several sales offices, the company is active worldwide and generates a turnover of around 150 million euros. CMS Germany Klaus Jäger, Lead Partner Dr Kai Wallisch, Part­ner Chris­toph Schröer, Senior Associate Dr Katharina Kapp, Associate Dr Henrik Meurer, As­so­ci­ate Domin­ic Zimmer, As­so­ci­ate Kath­rin Dengel, Associate, all Corporate/M&A Dr Björn Herbers, Partner Moritz Pottek, Counsel Dr Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate Dr Robert Bodewig, Senior Associate David Rappenglück, Associate, all Antitrust, Competition & Trade Dr Dirk Smielick, Principal Counsel Claudia Böhmer, Counsel, both IP Dr Angela Emmert, Partner Dr Andreas Hofelich, Partner Dr Mario Brungs, Counsel Lennard Martin Lürwer, Counsel Marcel Heinen, Senior Associate, all Labor, Employment & Pensions Michael Kamps, Partner Thorsten Hemme, Principal Counsel Dr Arne Schmieke, Senior Associate, all TMC Dr Martin Friedberg, Partner, Tax law Dr André Lippert, Partner Maike Füchtmann, Senior Associate, both Real Estate & Public Dorothée Janzen, Partner Dr Philipp Rohdenburg, Counsel, both Com­mer­cial Birgit Wagner, Legal Manager Conrad Gräwe, Legal Co­ordin­at­or Steven Washington, Legal Coordinator Anke Clippingdale, Senior Legal Specialist Edris Trabzadah, Senior Legal Specialist Faraz Ahmad, Legal Specialist Sofia Schreiner, Legal Spe­cial­ist Al­ex­an­der Stadahl, Legal Specialist, all Smart Operations CMS Beijing Falk Licht­en­stein Roxy Meng CMS Milan Daniela Murer Alessandra Cuni CMS Rome Fabrizio Spagnolo CMS Istanbul Döne Yalçın Merve Akkuş CMS Paris Thomas Hains Marion Berberian CMS Belgrade Maja Stepanović CMS Vienna Dr Dieter Zandler CMS London Russell Hoare Melanie Lane Focaccia Amaral L S Advogados, Brazil in association with CMS Renata Homem de Melo Fontes Carla Anastácio Lau, Horton & Wise LLP, Hong Kong in association with CMS Shirley Lau Albert Jok MILLER & MARTIN PLLC, USA Joe DeLisle Vaish Associates Advocates, India Shrinivas SankaranPress Con­tact presse@cms-hs. com
13/02/2024
CMS advises on sale of flexis AG to Blue Yonder
Stuttgart – The shareholders of flexis AG, a flexible, innovative software technology provider specializing in production optimization and transportation planning and execution, have sold all shares to Blue Yonder, a leading supply chain solutions provider. flexis AG specializes in the development of software-based technologies aimed at optimizing supply chain management (including ordering, production, planning and execution of transports). With the acquisition, Blue Yonder expands its portfolio with a stable customer base in the automotive and OEM sector and its offering to companies with highly configurable products and an extensive network of suppliers. The combined technologies of the two companies are intended to improve production planning, order fulfilment and supply chain performance for customers and thus offer added value. The parties involved have agreed not to disclose further details of the transaction.A CMS team headed by partner Dr Heiko Wiechers and Dr Andreas Lohbeck advised the shareholders of flexis AG on all legal aspects of this transaction that underlines again the team's strength in cross-border deals in the technology sector. flexis AG, headquartered in Stuttgart, specializes in flexible, innovative software for optimizing supply chain planning and execution. With seven locations worldwide, flexis AG can look back on more than 25 years of company history. Blue Yonder, based in Scottsdale, Arizona, U.S., is global market leader in digital supply chain trans­form­a­tions.  CMS Germany Dr Heiko Wiechers, Partner, Co-Lead Dr Andreas Lohbeck, Principal Counsel, Co-Lead Julia Fünfgeld, Senior Associate, all Corporate/M&A Dr Markus Kaulartz, Partner, TMC Dr Martin Mohr, Partner, Tax law  Birgit Wagner, Legal Manager Lisa Mattmann, Senior Legal Specialist, both Smart OperationsPress Con­tact presse@cms-hs. com
05/02/2024
CMS advises Savills Investment Management on sale of Hamburg office property...
Stuttgart – Savills Investment Management (Savills IM) has sold a 16,000 square metre office property in Hamburg to the Cells Group. The Cells Group is acquiring the Atrium Office building at Glock­en­gießer­wall 21/22 in Hamburg on behalf of Kuwait’s sovereign wealth fund. Located between the main railway station and the city centre, Atrium Office comprises a her­it­age-pro­tec­ted building constructed in 1908 and an annex that was refurbished in the 1990s. Up to now, the property was part of special fund Savills IM Real Invest 1. The parties have scheduled the transfer of rights and liabilities for the first quarter of 2024.A CMS team headed by partner Dr Volker Zerr advised Savills IM on all legal and tax aspects of the transaction. The CMS team regularly advises Savills on real estate transactions, with a recent example being the sale of a superstore in Berlin-Spandau on behalf of the European Retail Fund (ERF). CMS Germany Dr Volker Zerr, Lead Partner Sandra Scheib, Coun­sel Jac­queline Terhöven, Counsel, all Real Estate & Public Tobias Schneider, Partner, TaxPress Con­tact presse@cms-hs. com